ZETA
ZETA specialises in the engineering, development, manufacturing, automation, digitalisation and maintenance of customer-specific aseptic process...
Sandoz partners with Austria to boost antibiotics production
Swiss pharmaceutical company Novartis unit Sandoz has partnered with the Austrian Government to boost integrated...
Apeiron Biologics gets regulatory approvals for Phase II Covid-19 trial
Apeiron Biologics has secured approvals from regulatory agencies in Austria, Germany and Denmark to conduct...
OncoOne launches with €13m Series A funding
Austria-based OncoOne closed its Series A funding round with €13m raised. This financing will be...
JOANNEUM RESEARCH
JOANNEUM RESEARCH investigates the pharmacokinetics (PK) and pharmacodynamics (PD) of novel drugs, as well as...
Deals this week: GlaxoSmithKline, Incyte, Novo Nordisk
GlaxoSmithKline (GSK) and Pfizer have agreed to combine their consumer healthcare businesses with combined annual...
Sandoz and Ares Genetics partner to develop anti-infectives platform
Novartis division Sandoz has partnered with Ares Genetics to develop a digital anti-infectives platform to...
EIB to fund F2G Biotech’s anti-fungal drug research project
The European Investment Bank (EIB) has provided €24m in funding to Austria’s F2G Biotech to...
Boehringer Ingelheim’s Biopharmaceutical Production Facility in Vienna, Austria
Germany-based pharmaceutical company Boehringer Ingelheim is constructing a new large-scale cell culture (LSCC) facility at...
M&As this week: Cambrex Corporation, Boehringer Ingelheim, Supernus Pharmaceuticals
Cambrex Corporation has completed the previously announced acquisition of Halo Pharma (Halo) for $425m.